Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The US Viewpoint

      Cardiology

      S. Karger AG

      Government intervention, Health care services, organization, US viewpoint

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Health and medical care services are not yet subject to the laws of supply and demand or the impersonal effects of the economic market. However, finite resources mean that governments and other payers are forced to make trade-offs. The United States, which has relied most heavily on market forces for its medical system, is now moving towards greater government responsibility for organization and financing, if not delivery, of services. President Clinton has proposed a national program of unified organization, service delivery, and financing so as to improve access to the US health care system and control cost. The proposed plan will enfranchise upwards of 50 million people who currently have no, or limited, access to medical care. Therefore, the initial effects will be more care of all kinds being provided by physicians. Such increases of services will increase expenditure, at least over the short-term.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          978-3-8055-6144-0
          978-3-318-01954-4
          0008-6312
          1421-9751
          1994
          1994
          18 November 2008
          : 85
          : Suppl 1
          : 96-101
          Affiliations
          Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pa., USA
          Article
          176768 Cardiology 1994;85:96–101
          10.1159/000176768
          7743542
          © 1994 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Categories
          Session IV: Government Intervention in Cardiovascular Disease – Help or Hindrance?

          Comments

          Comment on this article